- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Assertio Therapeutics Inc (ASRT)
Assess today's live Assertio Therapeutics Inc (ASRT) share price, performance and insights using our live NASDAQ: ASRT stock exchange data.
Analyse the historical data and Assertio Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Assertio Therapeutics share price buy/sell indicators using real-time data (or discuss the Assertio Therapeutics (ASRT) stock price today with other investors in the Assertio Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ ASRT share price (ISIN: US04546C2052) to enhance your trading decisions with our free investment tools and resources.
What Is the Assertio Therapeutics Inc Share Price Today?
The Assertio Therapeutics share price today is 0.7374.
What Is the Stock Symbol for Assertio Therapeutics Inc
The stock symbol (or 'ticker') for Assertio Therapeutics Inc is "ASRT."
What Stock Exchange Does Assertio Therapeutics Inc Trade On?
Assertio Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Assertio Therapeutics Inc a Good Stock to Buy?
Determining whether Assertio Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Assertio Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Assertio Therapeutics share price buy/sell indicators using real-time data (or discuss the Assertio Therapeutics (ASRT) stock price today with other investors in the Assertio Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ ASRT share price (ISIN: US04546C2052) to enhance your trading decisions with our free investment tools and resources.
What Is the Assertio Therapeutics Inc Share Price Today?
The Assertio Therapeutics share price today is 0.7374.
What Is the Stock Symbol for Assertio Therapeutics Inc
The stock symbol (or 'ticker') for Assertio Therapeutics Inc is "ASRT."
What Stock Exchange Does Assertio Therapeutics Inc Trade On?
Assertio Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Assertio Therapeutics Inc a Good Stock to Buy?
Determining whether Assertio Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
0.7374
+0.0151(+2.09%)
Real-time Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.7009
0.7490
52 wk Range
0.6802
1.7980
ASRT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.70090.7490
52 wk Range
0.68021.7980
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ASRT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
3.0300
Upside
+310.90%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
Assertio Therapeutics Company Profile
Assertio Holdings, Inc., a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate pain in adults; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois.
Assertio Therapeutics Inc Earnings Call Summary for Q4/2024
- Q4 2024 revenue beat expectations at $32.18M, with EPS loss of $0.03, narrower than forecast; stock rose 1.32% after hours
- Rolvadon sales increased to $15.4M; Indosin maintained market share despite generic competition; gross margin decreased to 61%
- 2025 guidance: net sales $108M-$123M, adjusted EBITDA $10M-$19M; CEO hints at potential strategic acquisitions
- Challenges include increased competition, potential generic threats, and pressure on gross margins
- InvestingPro analysis suggests stock undervalued with EV/EBITDA of 4.34x; company expected to return to profitability this year
Last Updated: 12/03/2025, 21:14
Read Full TranscriptCompare ASRT to Peers and Sector
Metrics to compare | ASRT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipASRTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.3x | 4.7x | −0.5x | |
PEG Ratio | −0.03 | 0.07 | 0.00 | |
Price/Book | 0.6x | 1.7x | 2.6x | |
Price / LTM Sales | 0.6x | 4.6x | 3.0x | |
Upside (Analyst Target) | 315.3% | 128.0% | 56.4% | |
Fair Value Upside | Unlock | 1.8% | 9.9% | Unlock |
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 3.0300
(+310.90% Upside)
Earnings
Latest Release
Mar 12, 2025
EPS / Forecast
-0.03 / -0.04
Revenue / Forecast
32.18M / 28.67M
People Also Watch
FAQ
What Is the Assertio Therapeutics (ASRT) Stock Price Today?
The Assertio Therapeutics stock price today is 0.7374
What Stock Exchange Does Assertio Therapeutics Trade On?
Assertio Therapeutics is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Assertio Therapeutics?
The stock symbol for Assertio Therapeutics is "ASRT."
What Is the Assertio Therapeutics Market Cap?
As of today, Assertio Therapeutics market cap is 69.98M.
What is Assertio Therapeutics Earnings Per Share?
The Assertio Therapeutics EPS is -0.227.
What Is the Next Assertio Therapeutics Earnings Date?
Assertio Therapeutics will release its next earnings report on 11 May 2025.
From a Technical Analysis Perspective, Is ASRT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.